212 related articles for article (PubMed ID: 22035702)
21. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
Strauss SM; Astone JM; Hagan H; Des Jarlais DC
J Urban Health; 2004 Mar; 81(1):38-47. PubMed ID: 15047782
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
[TBL] [Abstract][Full Text] [Related]
23. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study.
Hiva S; Negar K; Mohammad-Reza P; Gholam-Reza G; Mohsen A; Ali-Asghar NG; Mohammed-Jafar S
BMC Public Health; 2020 Jun; 20(1):920. PubMed ID: 32532228
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
Smikle MF; Dowe G; Williams EM; Thesiger C
Hum Antibodies; 2000; 9(4):231-3. PubMed ID: 11341177
[TBL] [Abstract][Full Text] [Related]
25. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
27. Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.
Marufu M; Williams H; Hill SL; Tibble J; Verma S
J Med Virol; 2012 Nov; 84(11):1737-43. PubMed ID: 22997076
[TBL] [Abstract][Full Text] [Related]
28. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
[TBL] [Abstract][Full Text] [Related]
29. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
Strauss SM; Astone JM; Jarlais DD; Hagan H
Drug Alcohol Depend; 2004 Mar; 73(3):227-36. PubMed ID: 15036545
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
31. Missed opportunities for hepatitis C testing in opioid treatment programs.
Frimpong JA
Am J Public Health; 2013 Jun; 103(6):1028-30. PubMed ID: 23597374
[TBL] [Abstract][Full Text] [Related]
32. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
Ramasamy P; Lintzeris N; Sutton Y; Taylor H; Day CA; Haber PS
Addiction; 2010 Feb; 105(2):329-34. PubMed ID: 20078489
[TBL] [Abstract][Full Text] [Related]
33. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
Vassilev ZP; Strauss SM; Astone J; Des Jarlais DC
J Behav Health Serv Res; 2004; 31(2):208-16. PubMed ID: 15255228
[TBL] [Abstract][Full Text] [Related]
34. Current treatments for hepatitis.
Fleming J
J Infus Nurs; 2002; 25(6):379-82. PubMed ID: 12464795
[TBL] [Abstract][Full Text] [Related]
35. Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study.
Behrends CN; Kapadia SN; Schackman BR; Frimpong JA
J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):393-402. PubMed ID: 33346582
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.
Frimpong JA; D'Aunno T
Subst Abuse Treat Prev Policy; 2016 Apr; 11():13. PubMed ID: 27036115
[TBL] [Abstract][Full Text] [Related]
37. Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
Tenner CT; Herzog K; Chaudhari S; Bini EJ; Weinshel EH
Int J Clin Pract; 2012 Oct; 66(10):1009-13. PubMed ID: 22994334
[TBL] [Abstract][Full Text] [Related]
38. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
Brown JL; Gause NK; Lewis D; Winhusen T
J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
[TBL] [Abstract][Full Text] [Related]
39. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
[TBL] [Abstract][Full Text] [Related]
40. Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.
Frimpong JA; D'Aunno T; Helleringer S; Metsch LR
BMC Public Health; 2016 Jul; 16():666. PubMed ID: 27473519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
